🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the addition of "Kidney Solid Organ Rejection Test" (k...
Status
Completed
Location
National Institute of Medical Sciences and Health Salvador Zubiran
Start Date
2014-09
Trial ID
NCT02581436
Treatments Being Tested
This is an observational study to evaluate safety and efficacy outcomes in ...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2018-01-23
Trial ID
NCT03326076
This Phase 2 study is a multi-center, randomized, double-blind, placebo-con...
Status
Withdrawn
Location
Stromedix Investigative Site
Start Date
2010-09
Trial ID
NCT00878761
Treatments Being Tested
To prospectively test whether the detection of three-dimensional, cast-like...
Status
Completed
Location
University of North Carolina-CH Dept of Pathology
Start Date
2008-11
Trial ID
NCT01094691
Treatments Being Tested
In this study investigators will investigate whether early treatment of all...
Status
Completed
Location
University Hospital Basel, Transplantation Immunology & Nephrology
Start Date
2017-09-28
Trial ID
NCT03140514
Treatments Being Tested
Patients after kidney transplantation who develop donor-specific antibodies...
Status
Completed
Location
Charité-Universitätsmedizin
Start Date
2021-06-01
Trial ID
NCT04897438
Treatments Being Tested
Since 1991, the Banff classification has been the gold standard for definin...
Status
Unknown
Location
Paris Translational Centre for Organ Transplantation
Start Date
2016-01-01
Trial ID
NCT05306795
This study is designed to investigate a novel approach to offer more ESRD p...
Status
Not Yet Recruiting
Location
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Start Date
2026-09
Trial ID
NCT05725421
Treatments Being Tested
Glomerulonephritis (GN) is the leading cause of end-stage renal disease in ...
Status
Completed
Location
Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine
Start Date
2015-03
Trial ID
NCT02700516
Current therapy to prevent organ rejection relies on the use of calcineurin...
Status
Completed
Location
Buffalo General Hospital Multi-Organ Transplant Department
Start Date
2008-01
Trial ID
NCT00896012
Treatments Being Tested